)
)
)
Ymmunobio
Ymmunobio is a pre-clinical stage Biotech company focusing on first in class solid tumor treatments. Their novel target has superior properties (highest prevalence (up to 100% in some cancers), large presence (+17 solid tumors), if present 100% of tumor cells positiv and not expressed in normal tissue).
PoC with ADCs in vivo demonstrated.
Address
BaselSwitzerland
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)